• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP M.R.I. IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP M.R.I. IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Model Number 1808560
Device Problem Fracture (1260)
Patient Problems Erythema (1840); Scar Tissue (2060); Swelling/ Edema (4577)
Event Date 02/09/2022
Event Type  Injury  
Event Description
It was reported that approximately one year and six months post port placement, the patient allegedly experienced mild erythema and swelling along the catheter.It was further reported that hyperpigmentation and scarring was noted along the catheter.Furthermore, after infusion, slight palpable puffiness was noted adjacent to line around right clavicle.Reportedly, the catheter was broken at posterior side of the catheter and the catheter was removed.The current status of the patient is unknown.
 
Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.However, photos and an image were provided for review.The investigation of the reported event is currently underway.(expiry date: 12/2023).H11: section a through f: the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one powerport isp mri implantable port attached to a groshong catheter was received for evaluation and one image and two photos were provided for review.Visual, microscopic, tactile and functional evaluations were performed.A compound break was noted on the attached catheter.The edges of the compound break on the attached catheter were noted to be uneven.The surface was noted to be round and smooth in both regions.The photos shows the fractured catheter attached with the powerport.Therefore, the investigation is confirmed for the reported fracture issue.Furthermore, the clinical conditions alleged in the complaint cannot be confirmed.The definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documentation (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: b5, d4 (expiration date: 12/2023).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : see h10.
 
Event Description
It was reported that approximately one year and six months post port placement, the patient allegedly experienced mild erythema and swelling along the catheter after last cycle of chemo.It was further reported that hyperpigmentation and scarring was noted along the catheter.Furthermore, after infusion, slight palpable puffiness was noted adjacent to line around right clavicle.Reportedly, the catheter was broken at posterior side of the catheter and the catheter was removed and replaced.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT ISP M.R.I. IMPLANTABLE PORT, GROSHONG SINGLE-LUMEN, 8F
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key16680838
MDR Text Key312675828
Report Number3006260740-2023-01176
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741027116
UDI-Public(01)00801741027116
Combination Product (y/n)N
Reporter Country CodeHK
PMA/PMN Number
K063377
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number1808560
Device Catalogue Number1808560
Device Lot NumberREFR0074
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/08/2023
Initial Date FDA Received04/05/2023
Supplement Dates Manufacturer Received06/21/2023
Supplement Dates FDA Received06/26/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/12/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient SexMale
-
-